Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders

Scientific Reports(2024)10.1038/s41598-024-53661-5Source: DataRank Database

Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders is a research paper published in Scientific Reports (2024). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 4.73)OA: goldTopics (61)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Jin Myong Seok,Amy E. Wright ORCID,Itay Lotan ORCID,Takahisa Mikami ORCID,Natalia Drosu

Live enrichment

PubMed:38326464 PMC:PMC10850367 OpenAlex:https://openalex.org/W4391602380

National Institute for Health Care Management Foundation

Grant: AI130548

NIAID NIH HHS

Grant: R01 AI130548

National Institutes of Health

Grant: 5R01AI130548-05

Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica

FWCI

4.73

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-024-53661-5.pdf

GOLDhttps://www.nature.com/articles/s41598-024-53661-5.pdf

publisherhttps://www.nature.com/articles/s41598-024-53661-5.pdf

publisherhttps://www.nature.com/articles/s41598-024-53661-5

journalhttps://doi.org/10.1038/s41598-024-53661-5

Fields of Study

Multiple Sclerosis Research StudiesAutoimmune and Inflammatory Disorders ResearchPeripheral Neuropathies and DisordersMedicine0301 basic medicine03 medical and health sciences0302 clinical medicineHumansNeuromyelitis OpticaCytokinesAntigen-Antibody ComplexLeukocytes, MononuclearInterleukin-17Interleukin-6RituximabAutoantibodiesAquaporin 4Complement System ProteinsImmunoglobulin G

MeSH Terms

RituximabAntigen-Antibody ComplexAutoantibodiesComplement System ProteinsHumansImmunoglobulin GLeukocytes, MononuclearNeuromyelitis OpticaInterleukin-6CytokinesInterleukin-17Aquaporin 4

Keywords

ImmunologyNeuromyelitis opticaPeripheral blood mononuclear cellMedicineCytokineAquaporin 4Immune systemComplement systemAutoimmunityInterleukinAntibodyBiologyPathologyIn vitroTopic 3: Integrative BiomedicineInterleukin-6ScienceQInterleukin-17RAntigen-Antibody ComplexComplement System ProteinsArticleImmunoglobulin GLeukocytes, MononuclearHumansCytokinesFunction and Dysfunction of the Nervous SystemRituximabAutoantibodies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being